Key Trends and Insights into the CRISPR And Cas Gene Market: Growth Rate and Opportunities to 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the crispr and cas gene market right now?
The market size for crispr and cas gene has seen significant expansion in the recent past. Forecasts show that it will increase from $3.99 billion in 2024 to $4.85 billion in 2025, marking a compound annual growth rate (CAGR) of 21.7%. Several factors have driven this growth in the historical period, including heightened consumer consciousness, change in consumer preferences, surge in celebrity endorsements, the emergence of veganism, and the growth of social media influence.
How fast Is the crispr and cas gene market expected to grow, and what’s its future value?
Expectations are high for an exponential increase in the size of the crispr and cas gene market over the upcoming years. The anticipation is for the market to expand to $10.81 billion by 2029 with a compound annual growth rate (CAGR) of 22.2%. The predicted growth can be linked to various factors such as global extension of bans, an increase in conscious consumerism, the surfacing of new labels, initiatives towards consumer education, and beauty inclusivity. Notable trends during the forecast period include advancements in technology, product innovation, development of a circular beauty economy, focus on men’s grooming segment, as well as social justice and ethical sourcing.
Get your crispr and cas gene market report here!
https://www.thebusinessresearchcompany.com/report/crispr-and-cas-gene-global-market-report
What are the leading drivers of growth in the crispr and cas gene market?
The burgeoning emphasis on bespoke treatments is projected to stimulate the expansion of the CRISPR and Cas gene markets in the future. Bespoke treatments utilize a patient’s genetic blueprint to determine the best approach for disease diagnosis, prevention, and treatment. CRISPR and the Cas gene, especially Cas9, find utility in this tailored treatment approach, facilitating detailed alterations to an individual’s genetic make-up. This method shows potential for major advancements in creating customised treatments for genetic diseases, cancer and numerous other medical conditions. For example, in January 2023, the Personalized Medicine Coalition, a professional body based in the US, revealed that the Food and Drug Administration’s Center for Drug Evaluation and Research (CDER) had approved 37 new molecular entities (NMEs) in 2022. Among the 35 therapeutic NMEs, around 34%, which corresponds to 12 NMEs, are categorized as personalized medicines as per the Personalized Medicine Coalition (PMC). Consequently, the escalating demand for bespoke treatment modalities will foster the advancement of the CRISPR and Cas gene markets.
What are the key segments defining the crispr and cas gene market?
The crispr and cas gene market covered in this report is segmented –
1) By Product Type: Kits And Enzymes, Libraries, Design Tool, Antibodies, Other Products Types
2) By Service Type: Cell Line Engineering, gRNA Design, Microbial Gene Editing, DNA Synthesis
3) By Application: Clinical, Financial, Operational And Administrative
4) By End Use: Biotechnology And Pharmaceutical Companies, Academics And Government Research Institutes, Contract Research Organizations (CROs)
Subsegments:
1) By Kits And Enzymes: CRISPR Kits, Cas Enzymes, Grna Synthesis Kits
2) By Libraries: CRISPR Libraries For Gene Knockout, CRISPR Libraries For Gene Activation, Sgrna Libraries
3) By Design Tools: Online Design Platforms, Software For CRISPR Guide RNA Design, Custom Design Services
4) By Antibodies: Antibodies For Cas Proteins, Antibodies For Detection Of Edited Cells, Secondary Antibodies For Immunoassays
5) By Other Product Types: Delivery Systems, CRISPR-Related Consumables, Control Plasmids And Reagents
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13632&type=smp
Who are the key players steering the development of the crispr and cas gene market?
Major companies operating in the Crispr and cas gene market report are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., AstraZeneca plc., Danaher Corporation, Quest Diagnostics, Lonza Group AG, Bio-Rad Laboratories Inc., eGenesis, Novartis Institutes for BioMedical Research, Myriad Genetics Inc., GenScript, Takara Bio Inc., 23andMe Inc., Merck KGaA, Color Genomics Inc., Horizon Discovery Group PLC, Beam Therapeutics Inc., Intellia Therapeutics Inc., New England BioLabs, Recursion Pharmaceuticals Inc., Caribou Biosciences Inc., Cellectis S.A., Editas Medicine Inc.
What emerging trends are influencing the growth of the crispr and cas gene market?
Leading firms in the CRISPR and Cas gene marketplace are creating groundbreaking items such as CRISPR-driven cell-based gene therapies to expand their product range and establish a solid market presence. This approach utilizes CRISPR gene-editing technology to alter or fix genetic content within cells, offering a targeted and potentially game-changing solution for treating genetic abnormalities, diseases, and other health issues at a cellular level. For example, Vertex Pharmaceuticals Incorporated, a biopharmaceutical company based in the US, was granted authorization by the U.S. Food and Drug Administration (FDA) for CASGEVY (exagamglogene autotemcel [exa-cel]) in December 2023. CASGEVY, a unique CRISPR/Cas9 genome-edited gene therapy, is intended to manage sickle cell disease (SCD) in those aged 12 or older suffering recurrent vaso-occlusive crises. CASGEVY represents a novel medication with the capacity to provide transformative therapy for eligible sickle cell patients after a single administration. Given that CASGEVY treatment demands specialized knowledge in stem cell transplantation, Vertex is partnering with veteran institutions to establish a network of independently owned, approved treatment centres (ATCs) throughout the United States to ensure CASGEVY’s availability to patients.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13632
Which regions are most influential in expanding the crispr and cas gene market?
North America was the largest region in the CRISPR and Cas gene market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR and cas gene market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Cell & Gene Therapy Manufacturing Services Global Market Report 2024
Gene Delivery Technologies Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report
Nucleic Acid Based Gene Therapy Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
